Elevated Capital Advisors, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1802387
SANDY, UT
Position in REGN
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$3,117
-$746 QoQ
Shares Held
5
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,278
of 1,322 holders
Holding Since
Jun 2020
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Elevated Capital Advisors, LLC holds $3,117 across 1 Biotechnology name. REGN ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
5 | $3,117 |
All Filings in REGN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,117 | 5 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $3,863 | 5 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $3,859 | 5 | Shares | Sole | 2026-01-27 | |
| 2021-03-31 | $925,461 | 1,956 | Shares | Sole | 2021-04-21 | |
| 2020-12-31 | $824,668 | 1,707 | Shares | Sole | 2021-02-25 | |
| 2020-09-30 | $816,719 | 1,459 | Shares | Sole | 2020-11-27 | |
| 2020-06-30 | $1,036,506 | 1,662 | Shares | Sole | 2020-09-11 | |
| No filing history on record for this holder in this stock. | ||||||